| Astex Technology
| Astex is a fragment-based drug discovery company pioneering high-throughput x-ray crystallography to rapidly identify new drugs. Astex’s unique approach Pyramid™ is revolutionizing the role of protein structure in discovery, accelerating the pace and providing leads for targets intractable to conventional screening. Astex uses Pyramid™ to identify novel leads for proprietary and public domain targets in both 'in house' programs and in discovery collaborations with corporate partners. | |
• Show past press releases
• Edit this company
| CONTACT INFORMATION |  | |
Address:
Phone:
Fax:
Web:
Contact:
| 436, Cambridge Science Park
Milton Road
Cambridge CB4 0QA
United Kingdom
+44 (0) 1223 226200
+44 (0) 1223 226201
http://www.astex-technology.com
Jeremy Carmichael
+44 (0) 1223 226200 |
| COMPANY FACTS | | |
| Founded: | Dec 1999 | | Founders: | Dr Harren Jhoti , Prof Sir Tom Blundell FRS , Dr Chris Abell | | CEO: | Mr Timothy J Haines | | CTO or technical lead: | Dr Harren Jhoti (CSO) | | CFO or finance director: | | | Head of Sales: | Dr Nifgel Crockett (Commercial Director) | | Head of Marketing: | contact |
| | Stage: | Growth | | Category: | Biotechnology & Healthcare | | Sector: | Biotechnology | | Employees: | 100 | | Profitability: | Pre-revenue | | Funding raised: | Yes | | Funding sought: | No | | Seeking Partnerships: | Yes |
| NON-EXECUTIVE BOARD MEMBERS | | |
Peter Fellner, Chairman, Celltech Group p
Prof Sir Tom Blundell FRS, Head of Biochemistry, Cambridge University
Mark Carthy, Venture Partner, Oxford Bioscience
Dr Stephen Bunting, Director, Abingworth
Timothy J Rink, ioscience, Aurora B
Patrick Van Beneden, Investment Director, GIMV
| KEY CUSTOMERS | | |
Pharma and biotech companies
| KEY BUSINESS PARTNERS | | |
Schering AG
AstraZeneca
Mitsubishi
Aventis
Fujisawa
Institute of Cancer Research, Uk / CRT
Johnson & Johnson Pharmaceutical R&D
Cambridge Crystallographic Data Centre
| KEY COMPETITORS | | |
structure-based drug discovery companies
| CAPITAL RAISED | | |
To view this information you must be signed in and subscribed to the online dataservice, sign in here.
To read more about the Online data service click here |
| PUBLIC OFFERINGS | | |
| Date | Type | Exchange |
| No public offerings |
|
|
|
